The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

25 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
77
Identification and development of biphenyl substituted iminosugars as improved dual glucosylceramide synthase/neutral glucosylceramidase inhibitors.EBI
Leiden University
23
Discovery and characterization of an inhibitor of glucosylceramide synthase.EBI
Exelixis
53
Assessment of partially deoxygenated deoxynojirimycin derivatives as glucosylceramide synthase inhibitors.EBI
TBA
33
Discovery of a new class of glucosylceramide synthase inhibitors.EBI
Exelixis
26
Identification of Potent and Selective Glucosylceramide Synthase Inhibitors from a Library of N-Alkylated IminosugarsEBI
TBA
9
 
Synthesis and biological evaluation of four stereoisomers of PDMP-analogue, N-(2-decylamino-3-hydroxy-3-phenylprop-1-yl)-β-valienamine, and related compoundsEBI
TBA
4
Accumulation of glucosylceramide in murine testis, caused by inhibition of beta-glucosidase 2: implications for spermatogenesis.EBI
University of Oxford
6
Novel Fused Pyrazole Amide Analogs as Glucosylceramide Synthase Inhibitors for Treating Lysosomal Storage Diseases, Neurodegenerative Diseases, Cystic Diseases, and Cancer.EBI
Smith, Gambrell & Russell
6
Fused Pyrazole Urea Analogs as Glucosylceramide Synthase Inhibitors for Treating Diseases.EBI
Smith, Gambrell & Russell
20
Fluorinated Isoindolinone-Based Glucosylceramide Synthase Inhibitors with Low Human Dose Projections.EBI
Merck
15
Amphiphilic glycoconjugates as potential anti-cancer chemotherapeutics.EBI
Emory University
21
Pyrazole Ureas as Low Dose, CNS Penetrant Glucosylceramide Synthase Inhibitors for the Treatment of Parkinson's Disease.EBI
Merck
13
Photoredox-based late-stage functionalization in SAR study for in vivo potent glucosylceramide synthase inhibitor.EBI
Takeda Pharmaceutical
6
Modified Benzofuran-carboxamide Compounds as Glucosylceramide Synthase Inhibitors for Treating Diseases.EBI
Smith, Gambrell & Russell
26
Discovery of Brain-Penetrant Glucosylceramide Synthase Inhibitors with a Novel Pharmacophore.EBI
Takeda Pharmaceutical
2
New PDMP analogues inhibit process outgrowth in an insect cell line.EBI
University of Arizona
248
POLQ INHIBITORSBDB
AstraZeneca
68
Substituted 2-(pyrrolidine-3-yl)acetic acid derivative, preparation method and use thereofBDB
Innovstone Therapeutics
73
PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND METHODS OF USE THEREOFBDB
Calico Life Sciences
181
Benzo[c][2,6]naphthyridine derivatives, compositions and therapeutic uses thereofBDB
Cambridge Enterprise
6
HETEROARYL HETEROCYCLIC COMPOUNDS AND USES THEREOFBDB
Hutchison Medipharma
188
Substituted lactams showing serotonin 5-HT receptor activityBDB
Sumitomo Pharma
12
Heterocyclic compounds as FGFR inhibitorsBDB
Guangzhou Innocare Pharma Tech
12
Design, synthesis and anticholinesterase activity of some new a-aminobisphosphonates.BDB
Tarbiat Modares University
2
Synthesis, methods of using, and compositions of cycloalkylmethylaminesBDB
Reviva Pharmaceuticals